COMMUNIQUÉS West-GlobeNewswire

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26

05/02/2019 - 22:15

MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Globus Medical Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call

05/02/2019 - 22:15

AUDUBON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31 [...]

AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast

05/02/2019 - 22:15

Call scheduled for Wednesday, February 13th at 4:30pm Eastern Time. NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused [...]

aTyr Pharma to Present at the BIO CEO & Investor Conference

05/02/2019 - 22:05

SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States

05/02/2019 - 22:05

-- Three Antimicrobial Susceptibility Tests Cleared by FDA for Use with NUZYRA -- -- Launches KEYSTONE TM Surveillance Program to Monitor Omadacycline Susceptibility -- BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Paratek [...]

Myriad Genetics Reports Fiscal Second-Quarter 2019 Financial Results

05/02/2019 - 22:05

Total Second-Quarter Revenues of $216.8 Million, Up 15 Percent Second-Quarter Diluted EPS of $0.03 and Adjusted EPS of $0.38, Up 6 Percent SALT LAKE CITY, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ [...]

Emblem Corp. Announces Receipt of Interim Court Order and Mailing of Meeting Materials Related to its Special Meeting of Shareholders and Proposed Arrangement with Aleafia Health Inc.

05/02/2019 - 22:05

TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“ Emblem ” or the “ Company ”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for [...]

Cerner Reports Fourth Quarter and Full Year 2018 Results and Announces Plan to Initiate Quarterly Cash Dividend

05/02/2019 - 22:01

Fourth Quarter Bookings 2nd Highest in Cerner History KANSAS CITY, Mo., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2018 fourth quarter and full year that ended [...]

Amicus Therapeutics Announces Positive data in Pompe Disease Phase 1/2 Study for Up to 24 Months at 15th Annual WORLDSymposium™

05/02/2019 - 22:01

Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Continue for both ERT-Naïve and ERT-Switch Patients Patient Reported Outcomes Data Demonstrate Benefits in Activities of [...]

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05/02/2019 - 22:00

RADNOR, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]

Bone Therapeutics SA to present at the Annual Meeting of the Orthopaedic Research Society (ORS)

05/02/2019 - 20:08

Press release Gosselies, Belgium, 5 February 2019, 8pm CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, [...]

Agility Health Announces Corporate Update and Trading Resumption

05/02/2019 - 18:36

HAMILTON, Ontario, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Company ”) announces that two (2) of the Company’s operating subsidiaries, Ontario Orthotic Lab Inc. (“ [...]

Apellis’ APL-2 Receives Orphan Drug Designation from the FDA for the Treatment of Autoimmune Hemolytic Anemia

05/02/2019 - 18:02

CRESTWOOD, Ky., and WALTHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other Initiatives

05/02/2019 - 17:26

Toronto, ON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Provides Operational Update on its $2,600,000 CDN framing contract to build approximately 150 homes just [...]

Healthwise Announces Dr. Daniel Meltzer as Chief Medical Officer

05/02/2019 - 17:18

Healthwise today named Dr. Daniel Meltzer to be the next Healthwise CMO BOISE, Idaho, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, announced today [...]

OnePoint Patient Care Named One of “30 Most Attractive Companies” by The Silicon Review

05/02/2019 - 16:00

MORTON GROVE, Ill., Feb. 05, 2019 (GLOBE NEWSWIRE) -- OnePoint Patient Care, the nation’s leading provider of community-based hospice pharmacy and pharmacy benefits management (PBM) services, has been named one of the “ [...]

Zynerba Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference

05/02/2019 - 16:00

DEVON, Pa., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]

AVRA Medical Robotics, Inc. issues CEO letter to Shareholders

05/02/2019 - 15:48

ORLANDO, Fla., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Avra Medical Robotics, Inc. (OTCQB: AVMR) issues the following letter to Shareholders from the CEO: Dear Shareholder, Over 95% of you have been with the AVRA TEAM and me [...]

Ocutrx Vision Technologies Named to StartUp City’s List of 15 Most Promising Wearable Technology Startups

05/02/2019 - 15:10

IRVINE, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC , a California-based developer of augmented reality (AR) glasses, today announced the company’s inclusion into StartUp City’s annual list [...]